Thermo Fisher Pharma Services: COVID-19 Mobilization
We're working arm-in-arm with industry innovators, government agencies and academic institutions to provide scale, flexibility and expertise in the battle against COVID-19.
Learn More »
Thermo Fisher Scientific Opens New Bioprocessing Collaboration Center in St. Louis
The new Bioprocessing Collaboration Center (BCC) in St. Louis, Missouri, uniquely positions Thermo Fisher to bring together industry-leading expertise in single-use technologies and biologics product development and manufacturing to deliver unmatched value to our customers. The combined expertise from our bioproduction and pharma services businesses will accelerate innovation and enhance productivity for biopharma customers.
Thermo Fisher and CSL Enter Strategic Partnership to Provide Best-in-Class Pharma Services
To enhance our offering with expanded capabilities and to meet growing demand for biologic therapies, Thermo Fisher and global biotechnology company, CSL have entered into a strategic partnership. Thermo Fisher will support CSL’s product portfolio by leveraging its pharma services network, and through a long-term lease agreement with CSL, will operate a new state-of-the-art biologics manufacturing facility in Lengnau, Switzerland.
Thermo Fisher Scientific Doubles Capacity to Produce Cell & Gene Therapies
To support increasing demand for viral vector development and manufacturing services, we are expanding capacity with construction of a new commercial manufacturing site in Plainville, Mass. The 290,000-square-foot facility will more than double our commercial viral vector capacity to support customers who are developing and manufacturing gene therapies and vaccines to address unmet medical needs.
The Patheon Brand is Expanding to include Viral Vector Services and Clinical Trial Solutions
Our CDMO and clinical services offerings are now unified under the Patheon brand. Learn more about our full breadth of capabilities for pharma and biotech companies of all sizes, and how we can take your discovery from clinical to commercial.
